-
Real-world short-term outcomes and treatment regimen comparisons in patients with metastatic renal cell carcinoma treated with first-line immune combinations.
29 Jan 2025 09:08 GMT
… standard first-line treatment for patients with metastatic renal cell carcinoma (mRCC). This study … treated with either immune-oncologic drug doublet (IO-IO) or immune … -oncologic drug tyrosine kinase inhibitor combinations (IO …
-
Real-World Efficacy and Safety of Avelumab Plus Axitinib in Metastatic Renal Cell Carcinoma: Results from the Ambispective RAVE-Renal Study.
29 Jan 2025 09:08 GMT
… therapy for patients with metastatic renal cell carcinoma (mRCC).
RAVE-Renal was a … OS not reached. Any-grade treatment-related adverse events (TRAEs) occurred …
-
A Review of Neoadjuvant Therapy for Localized and Locally Advanced Renal Cell Carcinoma.
28 Jan 2025 10:45 GMT
… (IOs) have drastically altered the treatment landscape for kidney cancer, with … the standard front-line treatment for advanced renal cell carcinoma (RCC). However, the roles of … for locoregional/locally advanced RCC remain undefined, where the goals …
-
Breakthrough Drugs Set to Achieve Blockbuster Status by 2030
28 Jan 2025 23:22 GMT
… Drugs to Watch 2025, by Clarivate, provides an overview of breakthrough treatments … efficacy compared with existing treatments. The drug is expected to launch … oral administrated drug is being investigated in non-clear-cell renal cell carcinoma (nccRCC …
-
Identifying Drivers of Exceptional Response to Immunotherapy in Metastatic RCC
28 Jan 2025 21:21 GMT
Among treatment-naive patients with metastatic renal cell carcinoma (RCC), exceptional response to immunotherapy … 39;s DNA.
VEGF treatment: a drug that prevents the abnormal … to immune checkpoint inhibition in renal cell carcinoma” by Dr. Tejas Jammihal, …
-
RCC’s short-term training helps Casey Davis land a $20,000 scholarship
28 Jan 2025 20:45 GMT
… more about the profession through RCC’s Pharmacy Technician program. … a supervising pharmacist,” reads the RCC Health Occupations web page. … pharmacists as they provide medication and other health care … .
Davis was familiar with RCC, being that she is …
-
Effectiveness and Safety of Dupilumab and Tralokinumab for Treating Atopic Dermatitis and Pruritic Skin Disorders in Oncological Patients: A Narrative Review
30 Jan 2025 14:33 GMT
… and systematic reviews focusing on drugs. Non-English manuscripts were … not related to the study drug.12 Beyond clinical trials, … mg every six weeks for renal cell carcinoma, and the third was … these medications cannot be regarded as a safe treatment option for …
-
Nephrology and Urology Devices Business Research Report 2024-2030 - Strategic Focus on Telehealth Solutions Generates Opportunities - ResearchAndMarkets.com
30 Jan 2025 17:27 GMT
… on improving patient comfort, reducing treatment duration, and enhancing efficiency. … diagnosis, and targeted treatment of cancers like renal cell carcinoma and bladder cancer. … Benign Prostatic Hyperplasia (BPH) Treatment Devices
Urinary Incontinence and …
-
Dr Dizman on the Rationale of Evaluating CBM588 in Metastatic RCC
28 Jan 2025 00:37 GMT
… microbiome in patients with metastatic renal cell carcinoma (RCC) treated with immune checkpoint inhibitors … from enrolled patients with metastatic RCC who were treated with either … plus SOC as first-line treatment. Data demonstrated that in both …
-
Merck Given Priority Review for WELIREG® Application for the Treatment of Adrenal Tumors
27 Jan 2025 19:24 GMT
… priority review a supplemental new drug application (sNDA) seeking approval … (HIF-2α) inhibitor, for the treatment of adult and pediatric patients … who require therapy for associated renal cell carcinoma (RCC), central nervous system hemangioblastomas, or …
About
© 1995-2025